Arndt Justus Georg Schottelius
Fortune : 61 196 $ au 31/08/2026
Fortune : 61 196 $ au 31/08/2026
Dr. Arndt Justus Georg Schottelius is a Chief Executive Officer at Maxion Therapeutics Ltd. and an Independent Director at Gubra A/S.
He is on the Board of Directors at Gubra A/S.
Dr. Schottelius was previously employed as a Chief Scientific Officer by Affimed NV, an Executive VP & Head-Research & Development by Kymab Ltd., a Medical Director-Immunology Development by Genentech, Inc., and a Chief Development Officer by MorphoSys AG.
He received his doctorate degree from the University of Freiburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GUBRA A/S 0,01% | 31/12/2025 | 1 038 ( 0,01% ) | 61 196 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GUBRA A/S | Directeur/Membre du Conseil | 01/01/2022 |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Directeur Général | 01/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| AFFIMED N.V. | Directeur Technique/Scientifique/R&D | 29/02/2024 |
| MORPHOSYS AG | Corporate Officer/Principal | 01/03/2017 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Directeur Technique/Scientifique/R&D | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Affimed NV
Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Maxion Therapeutics Ltd.
Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures protein therapeutics for cardiovascular, autoimmune and chronic disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national